Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery

PURPOSE: The recommended treatment for small-cell lung cancer (SCLC) currently is surgery in stage I disease. We wondered about stage II SCLC and present a meta-analysis on mean-survival of patients that underwent surgery for stage I and II compared to controls. METHODS: A systematic literature sear...

Descripción completa

Detalles Bibliográficos
Autores principales: Doerr, Fabian, Stange, Sebastian, Michel, Maximilian, Schlachtenberger, Georg, Menghesha, Hruy, Wahlers, Thorsten, Hekmat, Khosro, Heldwein, Matthias B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360162/
https://www.ncbi.nlm.nih.gov/pubmed/35768664
http://dx.doi.org/10.1007/s00408-022-00549-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360162/
https://www.ncbi.nlm.nih.gov/pubmed/35768664
http://dx.doi.org/10.1007/s00408-022-00549-8

Ejemplares similares